• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性T淋巴细胞相关分子4是一种与CD80和CD86具有高亲和力的受体,其胞质尾部含有一个细胞内定位基序。

Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail.

作者信息

Leung H T, Bradshaw J, Cleaveland J S, Linsley P S

机构信息

Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.

出版信息

J Biol Chem. 1995 Oct 20;270(42):25107-14. doi: 10.1074/jbc.270.42.25107.

DOI:10.1074/jbc.270.42.25107
PMID:7559643
Abstract

CD28 and CTLA-4, T cell receptors for B7-1 (CD80) and B7-2 (CD86) molecules on antigen-presenting cells, transmit costimulatory signals important for optimal T cell activation. Despite sharing sequence homology and common ligands, these receptors have distinct binding properties and patterns of expression. The function of CTLA-4 during T cell activation is not well understood, although an important role is suggested by complete amino acid sequence conservation of its cytoplasmic tail in all species studied to date. We report here a role of the cytoplasmic tail of CTLA-4 in regulating its subcellular localization and cell surface expression. In activated human peripheral blood T cells, or in several transfected or transduced cell types, CTLA-4 is not primarily a cell surface protein, but rather is localized intracellularly in a region which overlaps the Golgi apparatus. Transfer of 11 cytoplasmic residues, 161TTGVYVKMPPT, from the CTLA-4 cytoplasmic tail to the homologous position in CD28 was sufficient to confer intracellular localization. Mutation of the tyrosine residue (Tyr165) in this motif to phenylalanine resulted in increased surface expression of CTLA-4. Thus, the subcellular localization of CTLA-4 is controlled by a tyrosine-containing motif within its cytoplasmic domain. Contained within this motif is a binding site for SH2 domains of the p85 subunit of phosphatidylinositol 3-kinase.

摘要

CD28和CTLA-4是抗原呈递细胞上B7-1(CD80)和B7-2(CD86)分子的T细胞受体,可传递对最佳T细胞活化至关重要的共刺激信号。尽管这些受体具有序列同源性和共同的配体,但它们具有不同的结合特性和表达模式。尽管迄今为止在所有研究的物种中其胞质尾部的氨基酸序列完全保守,提示其具有重要作用,但CTLA-4在T细胞活化过程中的功能尚未完全明确。我们在此报告CTLA-4的胞质尾部在调节其亚细胞定位和细胞表面表达中的作用。在活化的人外周血T细胞中,或在几种转染或转导的细胞类型中,CTLA-4主要不是细胞表面蛋白,而是定位于细胞内与高尔基体重叠的区域。将CTLA-4胞质尾部的11个胞质残基(161TTGVYVKMPPT)转移至CD28的同源位置足以使其定位于细胞内。将该基序中的酪氨酸残基(Tyr165)突变为苯丙氨酸导致CTLA-4的表面表达增加。因此,CTLA-4的亚细胞定位由其胞质结构域内的一个含酪氨酸基序控制。该基序内含有磷脂酰肌醇3激酶p85亚基SH2结构域的结合位点。

相似文献

1
Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail.细胞毒性T淋巴细胞相关分子4是一种与CD80和CD86具有高亲和力的受体,其胞质尾部含有一个细胞内定位基序。
J Biol Chem. 1995 Oct 20;270(42):25107-14. doi: 10.1074/jbc.270.42.25107.
2
Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.CD28/CTLA-4的共价二聚化以及CD80/CD86的寡聚化调节T细胞共刺激相互作用。
J Biol Chem. 1996 Oct 25;271(43):26762-71. doi: 10.1074/jbc.271.43.26762.
3
Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.细胞毒性T淋巴细胞相关分子4(CTLA-4)的结合化学计量学。一个二硫键连接的同型二聚体结合两个CD86分子。
J Biol Chem. 1995 Jun 23;270(25):15417-24. doi: 10.1074/jbc.270.25.15417.
4
Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.人CTLA-4的溶液结构以及CD28中保守的CD80/CD86结合位点的描绘。
Nat Struct Biol. 1997 Jul;4(7):527-31. doi: 10.1038/nsb0797-527.
5
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.人B7-1(CD80)和B7-2(CD86)与CD28和CTLA-4受体结合时亲和力相似,但动力学特性不同。
Immunity. 1994 Dec;1(9):793-801. doi: 10.1016/s1074-7613(94)80021-9.
6
Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.共刺激分子CD80和CD86及其受体CD28、CTLA-4在卵巢癌及其他类型腹膜癌患者恶性腹水中CD3⁺肿瘤浸润淋巴细胞(TIL)上的表达。
Clin Exp Immunol. 2000 Jan;119(1):19-27. doi: 10.1046/j.1365-2249.2000.01105.x.
7
Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28.CD80的两个细胞外免疫球蛋白样结构域都含有与T细胞表面受体CTLA-4和CD28结合至关重要的残基。
J Biol Chem. 1995 Sep 8;270(36):21181-7. doi: 10.1074/jbc.270.36.21181.
8
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.CD28 对其同源反受体 CD80(B7.1)和 B70(B7.2)的差异识别:定点诱变分析
Mol Immunol. 1996 Feb;33(3):321-34. doi: 10.1016/0161-5890(95)00077-1.
9
Interaction of the cytoplasmic tail of CTLA-4 (CD152) with a clathrin-associated protein is negatively regulated by tyrosine phosphorylation.细胞毒性T淋巴细胞相关抗原4(CTLA-4,即CD152)胞质尾与网格蛋白相关蛋白的相互作用受到酪氨酸磷酸化的负调控。
Biochemistry. 1997 Dec 16;36(50):15975-82. doi: 10.1021/bi971762i.
10
Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement.细胞毒性T淋巴细胞相关抗原4(CTLA-4)的细胞内运输及向T细胞受体(TCR)结合位点的局灶定位
Immunity. 1996 Jun;4(6):535-43. doi: 10.1016/s1074-7613(00)80480-x.

引用本文的文献

1
Parkinson's disease: exploring the systemic immune mechanisms through molecular investigations.帕金森病:通过分子研究探索全身免疫机制
Inflammopharmacology. 2025 Jun 23. doi: 10.1007/s10787-025-01816-9.
2
Unravelling T cell exhaustion through co-inhibitory receptors and its transformative role in cancer immunotherapy.通过共抑制受体解析T细胞耗竭及其在癌症免疫治疗中的变革性作用。
Clin Transl Med. 2025 May;15(5):e70345. doi: 10.1002/ctm2.70345.
3
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy.
用于个性化治疗和提高疗效的革命性癌症疗法:克服免疫检查点抑制剂疗法耐药性的策略
Cancers (Basel). 2025 Mar 4;17(5):880. doi: 10.3390/cancers17050880.
4
Rapid turnover of CTLA4 is associated with a complex architecture of reversible ubiquitylation.CTLA4 的快速周转与可逆泛素化的复杂结构有关。
J Cell Biol. 2025 Jan 6;224(1). doi: 10.1083/jcb.202312141. Epub 2024 Oct 15.
5
Mechanistic Insights into the Inhibition of a Common CTLA-4 Gene Mutation in the Cytoplasmic Domain.细胞质结构域中常见 CTLA-4 基因突变抑制的机制研究
Molecules. 2024 Mar 16;29(6):1330. doi: 10.3390/molecules29061330.
6
Rapid turnover of CTLA4 is associated with a complex architecture of reversible ubiquitylation.CTLA4的快速周转与可逆泛素化的复杂结构相关。
bioRxiv. 2024 Jan 1:2023.12.31.573735. doi: 10.1101/2023.12.31.573735.
7
Five Inhibitory Receptors Display Distinct Vesicular Distributions in Murine T Cells.五种抑制性受体在小鼠 T 细胞中呈现不同的囊泡分布。
Cells. 2023 Oct 31;12(21):2558. doi: 10.3390/cells12212558.
8
CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis.CTLA4 通过顺式内吞作用耗竭 T 细胞内源性和转胞吞作用的 B7 配体。
J Exp Med. 2023 Jul 3;220(7). doi: 10.1084/jem.20221391. Epub 2023 Apr 12.
9
Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish.硬骨鱼类原始共刺激分子 CD80/86 及其受体 CD28 和 CD152(CTLA-4)的分子和功能分析。
Front Immunol. 2022 Jun 16;13:885005. doi: 10.3389/fimmu.2022.885005. eCollection 2022.
10
Molecular Pathways and Mechanisms of LAG3 in Cancer Therapy.LAG3 在癌症治疗中的分子途径和机制。
Clin Cancer Res. 2022 Dec 1;28(23):5030-5039. doi: 10.1158/1078-0432.CCR-21-2390.